Julia Reusch
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
-
- Hepatitis Viruses Studies and Epidemiology
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
-
- Acute Myeloid Leukemia Research 2
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Cyrus Khandanpour (2 shared papers)Judith Schütte (1 shared paper)Lars Dölken (4 shared papers)Helmut R. Salih (1 shared paper)Stefan Frantz (4 shared papers)Lukas B. Krone (2 shared papers)Alexander Gabel (4 shared papers)Hartmut Schmidt (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Journal of Sleep Research (1 paper)Frontiers in Oncology (1 paper)Journal of Medical Virology (1 paper)Pathogens (1 paper)
- Partner nations
- GermanySwitzerlandUnited Kingdom
In The Last Decade
Julia Reusch
9 papers receiving 52 citations
Peers
Comparison fields: 5 of 28
- Infectious Diseases 17
- Hepatology 6
- Hematology 8
- Immunology 10
- Oncology 10
Countries citing papers authored by Julia Reusch
This map shows the geographic impact of Julia Reusch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Reusch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Reusch more than expected).
Fields of papers citing papers by Julia Reusch
This network shows the impact of papers produced by Julia Reusch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Reusch. The network helps show where Julia Reusch may publish in the future.
Co-authors
The 25 scholars most cited alongside Julia Reusch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 11 | |
| 2 | 2019 | 9 | |
| 3 | 2019 | 7 | |
| 4 | 2022 | 7 | |
| 5 | 2023 | 6 | |
| 6 | 2020 | 6 | |
| 7 | 2024 | 3 | |
| 8 | 2020 | 2 | |
| 9 | 2023 | 1 |
About Julia Reusch
Julia Reusch is a scholar working on Infectious Diseases, Hematology, Oncology, Immunology and Molecular Biology, having authored 9 papers that have together received 52 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Acute Myeloid Leukemia Research (2 papers), Multiple Myeloma Research and Treatments (2 papers), COVID-19 Clinical Research Studies (2 papers), Acute Lymphoblastic Leukemia research (1 paper), Hepatitis Viruses Studies and Epidemiology (1 paper), Immunotherapy and Immune Responses (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Infectious Diseases (17 citations), Hepatology (6 citations), Hematology (8 citations), Immunology (10 citations) and Oncology (10 citations). Julia Reusch has collaborated with scholars based in Germany, Switzerland and United Kingdom. Frequent co-authors include Cyrus Khandanpour, Judith Schütte, Lars Dölken, Helmut R. Salih, Stefan Frantz, Lukas B. Krone, Alexander Gabel, Hartmut Schmidt, Patrick Behrendt and Alexandra Schubert‐Unkmeir. Their work appears in journals such as Journal of Clinical Oncology, Journal of Sleep Research, Frontiers in Oncology, Journal of Medical Virology and Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.